iRadimed Corporation Company Profile (NASDAQ:IRMD)

About iRadimed Corporation (NASDAQ:IRMD)

iRadimed Corporation logoIRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:IRMD
  • CUSIP: N/A
  • Web: www.iradimed.com
Capitalization:
  • Market Cap: $101.59 million
  • Outstanding Shares: 10,582,000
Average Prices:
  • 50 Day Moving Avg: $9.94
  • 200 Day Moving Avg: $8.89
  • 52 Week Range: $7.85 - $18.00
P/E:
  • Trailing P/E Ratio: 39.96
  • Foreward P/E Ratio: 86.82
  • P/E Growth: 4.22
Sales & Book Value:
  • Annual Revenue: $24.35 million
  • Price / Sales: 4.15
  • Book Value: $2.96 per share
  • Price / Book: 3.23
Profitability:
  • EBIDTA: $4.51 million
  • Net Margins: 11.61%
  • Return on Equity: 8.98%
  • Return on Assets: 7.69%
Debt:
  • Current Ratio: 9.09%
  • Quick Ratio: 7.91%
Misc:
  • Average Volume: 35,655 shs.
  • Beta: 1.5
  • Short Ratio: 32.32
 

Frequently Asked Questions for iRadimed Corporation (NASDAQ:IRMD)

What is iRadimed Corporation's stock symbol?

iRadimed Corporation trades on the NASDAQ under the ticker symbol "IRMD."

How will iRadimed Corporation's stock buyback program work?

iRadimed Corporation announced that its board has initiated a stock repurchase plan on Sunday, June 4th 2017, which allows the company to repurchase $8,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its shares are undervalued.

How were iRadimed Corporation's earnings last quarter?

iRadimed Corporation (NASDAQ:IRMD) announced its earnings results on Friday, July, 28th. The company reported $0.06 EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.01) by $0.07. The company earned $5.50 million during the quarter, compared to analyst estimates of $5.41 million. iRadimed Corporation had a return on equity of 8.98% and a net margin of 11.61%. The company's quarterly revenue was down 44.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.24 earnings per share. View iRadimed Corporation's Earnings History.

When will iRadimed Corporation make its next earnings announcement?

iRadimed Corporation is scheduled to release their next quarterly earnings announcement on Friday, October, 27th 2017. View Earnings Estimates for iRadimed Corporation.

What guidance has iRadimed Corporation issued on next quarter's earnings?

iRadimed Corporation issued an update on its third quarter earnings guidance on Friday, July, 28th. The company provided earnings per share guidance of $0.02-0.03 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.03. The company issued revenue guidance of $5.5-5.6 million, compared to the consensus revenue estimate of $5.76 million.

Where is iRadimed Corporation's stock going? Where will iRadimed Corporation's stock price be in 2017?

1 brokerages have issued 12 month price objectives for iRadimed Corporation's stock. Their forecasts range from $12.00 to $12.00. On average, they anticipate iRadimed Corporation's stock price to reach $12.00 in the next twelve months. View Analyst Ratings for iRadimed Corporation.

Who are some of iRadimed Corporation's key competitors?

Who are iRadimed Corporation's key executives?

iRadimed Corporation's management team includes the folowing people:

  • Roger Susi, Chairman of the Board, President, Chief Executive Officer, Founder
  • Chris Scott, Chief Financial Officer, Secretary
  • John McCreery, Chief Operating Officer
  • Brent Johnson, Executive Vice President - Worldwide Sales and Marketing
  • Fran Casey, Vice President - Regulatory and Quality Assurance
  • Steve Nardi, Vice President - Manufacturing
  • Louis Waldman, Controller
  • Jonathan A. Kennedy, Director
  • Anthony Vuoto, Director
  • Monty K. Allen, Independent Director

Who owns iRadimed Corporation stock?

iRadimed Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Ameriprise Financial Inc. (3.22%), Mondrian Investment Partners LTD (1.93%), Vanguard Group Inc. (1.69%), Granite Investment Partners LLC (1.05%), Menta Capital LLC (0.66%) and Spark Investment Management LLC (0.62%). Company insiders that own iRadimed Corporation stock include Brent Johnson, James B Hawkins, Monty K Allen, Roger E Susi, Serge Novovich and Steven M Nardi. View Institutional Ownership Trends for iRadimed Corporation.

Who sold iRadimed Corporation stock? Who is selling iRadimed Corporation stock?

iRadimed Corporation's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Northern Trust Corp, OxFORD Asset Management LLP, Bank of New York Mellon Corp, Granite Investment Partners LLC and Spark Investment Management LLC. View Insider Buying and Selling for iRadimed Corporation.

Who bought iRadimed Corporation stock? Who is buying iRadimed Corporation stock?

iRadimed Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Citigroup Inc., Menta Capital LLC, Neuberger Berman Group LLC, Connors Investor Services Inc. and Federated Investors Inc. PA. View Insider Buying and Selling for iRadimed Corporation.

How do I buy iRadimed Corporation stock?

Shares of iRadimed Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is iRadimed Corporation's stock price today?

One share of iRadimed Corporation stock can currently be purchased for approximately $9.55.


MarketBeat Community Rating for iRadimed Corporation (NASDAQ IRMD)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about iRadimed Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for iRadimed Corporation (NASDAQ:IRMD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.00 (25.65% upside)

Analysts' Ratings History for iRadimed Corporation (NASDAQ:IRMD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/31/2017Roth CapitalUpgradeNeutral -> Buy$9.00 -> $12.00MediumView Rating Details
(Data available from 9/23/2015 forward)

Earnings

Earnings History for iRadimed Corporation (NASDAQ:IRMD)
Earnings by Quarter for iRadimed Corporation (NASDAQ:IRMD)
Earnings History by Quarter for iRadimed Corporation (NASDAQ IRMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017$0.03N/AView Earnings Details
7/28/2017Q2 2017($0.01)$0.06$5.41 million$5.50 millionViewN/AView Earnings Details
4/28/2017Q1 2017($0.02)($0.02)$5.26 million$5.16 millionViewN/AView Earnings Details
2/6/2017Q416$0.04$0.11$6.09 million$6.00 millionViewListenView Earnings Details
10/28/2016Q316$0.09$0.14$7.50 million$7.70 millionViewListenView Earnings Details
7/29/2016Q216$0.21$0.24$9.60 million$9.90 millionViewListenView Earnings Details
4/29/2016Q1$0.18$0.21$9.05 million$8.96 millionViewListenView Earnings Details
2/5/2016Q415$0.19$0.22$8.80 million$8.80 millionViewN/AView Earnings Details
10/30/2015Q315$0.16$0.19$7.70 million$8.20 millionViewListenView Earnings Details
7/30/2015Q215$0.12$0.15$7.10 million$7.60 millionViewListenView Earnings Details
4/30/2015Q115$0.10$0.12$6.90 million$7.00 millionViewN/AView Earnings Details
2/5/2015Q4($0.01)$0.02$3.50 million$3.58 millionViewN/AView Earnings Details
10/30/2014Q3$0.01$0.02$3.80 million$3.80 millionViewN/AView Earnings Details
8/12/2014Q214$0.11$2.80 million$4.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for iRadimed Corporation (NASDAQ:IRMD)
2017 EPS Consensus Estimate: $0.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.02)($0.02)($0.02)
Q2 20171$0.00$0.00$0.00
Q3 20171$0.03$0.03$0.03
Q4 20171$0.07$0.07$0.07
(Data provided by Zacks Investment Research)

Dividends

Dividend History for iRadimed Corporation (NASDAQ:IRMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for iRadimed Corporation (NASDAQ:IRMD)
Insider Ownership Percentage: 60.10%
Institutional Ownership Percentage: 14.19%
Insider Trades by Quarter for iRadimed Corporation (NASDAQ:IRMD)
Institutional Ownership by Quarter for iRadimed Corporation (NASDAQ:IRMD)
Insider Trades by Quarter for iRadimed Corporation (NASDAQ:IRMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2017Steven M NardiVPSell4,634$8.32$38,554.88View SEC Filing  
2/9/2017Roger E SusiCEOBuy10,000$8.60$86,000.00View SEC Filing  
11/29/2016Roger E SusiCEOBuy5,000$11.24$56,200.00View SEC Filing  
11/15/2016Roger E SusiCEOBuy5,000$10.46$52,300.00View SEC Filing  
8/16/2016Steven M NardiVPSell2,096$17.11$35,862.56View SEC Filing  
6/14/2016Monty K. AllenDirectorSell2,275$20.00$45,500.00View SEC Filing  
6/13/2016Monty K AllenDirectorSell2,100$20.44$42,924.00View SEC Filing  
2/19/2016Serge NovovichDirectorSell2,910$17.23$50,139.30View SEC Filing  
2/18/2016Steven M NardiVPSell192$17.00$3,264.00View SEC Filing  
12/23/2015Roger E SusiCEOSell156,521$23.28$3,643,808.88View SEC Filing  
12/18/2015Roger E SusiCEOSell1,043,479$23.28$24,292,191.12View SEC Filing  
12/16/2015Steven M. NardiVPSell4,438$26.80$118,938.40View SEC Filing  
12/8/2015Brent JohnsonVPSell22,659$30.92$700,616.28View SEC Filing  
12/7/2015Steven M. NardiVPSell624$31.02$19,356.48View SEC Filing  
12/4/2015Brent JohnsonVPSell400$31.51$12,604.00View SEC Filing  
12/3/2015Brent JohnsonVPSell26,880$31.52$847,257.60View SEC Filing  
12/1/2015Serge NovovichDirectorSell1,000$31.12$31,120.00View SEC Filing  
11/25/2015James B. HawkinsDirectorSell5,290$30.98$163,884.20View SEC Filing  
8/25/2015Monty K. AllenDirectorSell6,250$24.85$155,312.50View SEC Filing  
12/29/2014Steven M NardiVPBuy2,100$12.58$26,418.00View SEC Filing  
7/21/2014James B HawkinsDirectorBuy80,000$6.25$500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for iRadimed Corporation (NASDAQ:IRMD)
Latest Headlines for iRadimed Corporation (NASDAQ:IRMD)
Source:
DateHeadline
finance.yahoo.com logoIRADIMED CORPORATION to Present at Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 18 at 7:26 PM
americanbankingnews.com logoEntellus Medical (ENTL) and iRadimed Corporation (NASDAQ:IRMD) Critical Comparison
www.americanbankingnews.com - August 7 at 4:28 PM
americanbankingnews.com logoZacks Investment Research Upgrades iRadimed Corporation (IRMD) to Buy
www.americanbankingnews.com - August 5 at 12:40 AM
americanbankingnews.com logoReviewing Entellus Medical (ENTL) & iRadimed Corporation (NASDAQ:IRMD)
www.americanbankingnews.com - August 5 at 12:12 AM
americanbankingnews.com logoiRadimed Corporation (IRMD) versus Penumbra (PEN) Head to Head Analysis
www.americanbankingnews.com - August 4 at 10:16 PM
finance.yahoo.com logoCorporate News Blog - Cesca Therapeutics Announces Issuance of New Cellular Processing Patent
finance.yahoo.com - July 31 at 7:23 PM
americanbankingnews.com logoAnalysts Anticipate iRadimed Corporation (NASDAQ:IRMD) to Post $0.00 EPS
www.americanbankingnews.com - July 31 at 2:34 PM
americanbankingnews.com logoiRadimed Corporation (NASDAQ:IRMD) Upgraded to Buy by Roth Capital
www.americanbankingnews.com - July 31 at 9:09 AM
finance.yahoo.com logoIRADIMED CORPORATION Announces Second Quarter 2017 Financial Results
finance.yahoo.com - July 28 at 11:34 PM
finance.yahoo.com logoEdited Transcript of IRMD earnings conference call or presentation 28-Jul-17 3:00pm GMT
finance.yahoo.com - July 28 at 11:34 PM
americanbankingnews.com logoiRadimed Corporation (IRMD) Announces Earnings Results
www.americanbankingnews.com - July 28 at 10:30 PM
americanbankingnews.com logoAnalysts Anticipate iRadimed Corporation (NASDAQ:IRMD) to Announce ($0.01) Earnings Per Share
www.americanbankingnews.com - July 28 at 8:44 PM
americanbankingnews.com logoiRadimed Corporation (IRMD) Updates Q3 Earnings Guidance
www.americanbankingnews.com - July 28 at 9:46 AM
americanbankingnews.com logoiRadimed Corporation (IRMD) Scheduled to Post Earnings on Friday
www.americanbankingnews.com - July 27 at 12:39 PM
seekingalpha.com logoiRadimed Corp. (IRMD)
seekingalpha.com - July 23 at 3:15 AM
americanbankingnews.com logoCritical Review: iRadimed Corporation (IRMD) & Masimo Corporation (MASI)
www.americanbankingnews.com - July 18 at 12:27 AM
americanbankingnews.com logoFinancial Contrast: Entellus Medical (ENTL) and iRadimed Corporation (NASDAQ:IRMD)
www.americanbankingnews.com - July 16 at 4:24 PM
americanbankingnews.com logoHead-To-Head Analysis: iRadimed Corporation (NASDAQ:IRMD) and Tactile Systems Technology (TCMD)
www.americanbankingnews.com - July 15 at 2:18 PM
americanbankingnews.com logoCritical Survey: Iradimed Corp (IRMD) and Entellus Medical (ENTL)
www.americanbankingnews.com - July 10 at 12:20 PM
americanbankingnews.com logoReviewing iRadimed Corporation (IRMD) & Penumbra (PEN)
www.americanbankingnews.com - July 7 at 10:20 PM
americanbankingnews.com logoiRadimed Corporation (NASDAQ:IRMD) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - July 2 at 11:28 AM
americanbankingnews.com logoiRadimed Corporation (IRMD) Stock Rating Upgraded by TheStreet
www.americanbankingnews.com - June 27 at 3:28 PM
finance.yahoo.com logoIRadimed Corp.: Gathering momentum, can it sustain its performance?
finance.yahoo.com - June 26 at 7:48 PM
americanbankingnews.com logoZacks: iRadimed Corporation (IRMD) Given $10.00 Average Price Target by Brokerages
www.americanbankingnews.com - June 26 at 4:32 PM
americanbankingnews.com logoiRadimed Corporation (IRMD) Downgraded by ValuEngine to Sell
www.americanbankingnews.com - June 24 at 10:22 PM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : June 5, 2017
finance.yahoo.com - June 5 at 6:00 PM
americanbankingnews.com logoIradimed Corp (IRMD) to Repurchase $8.00 million in Stock
www.americanbankingnews.com - June 4 at 11:28 AM
americanbankingnews.com logoIradimed Corp (IRMD) VP Steven M. Nardi Sells 4,634 Shares
www.americanbankingnews.com - June 1 at 8:32 PM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : May 22, 2017
finance.yahoo.com - May 22 at 5:27 PM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : May 9, 2017
finance.yahoo.com - May 9 at 5:45 PM
finance.yahoo.com logoIRadimed Corp. :IRMD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017
finance.yahoo.com - May 8 at 5:37 PM
americanbankingnews.com logoSomewhat Negative Media Coverage Likely to Impact Iradimed Corp (IRMD) Share Price
www.americanbankingnews.com - May 2 at 9:38 PM
americanbankingnews.com logoIradimed Corp (IRMD) Earns Daily News Impact Score of 0.04
www.americanbankingnews.com - April 29 at 11:59 PM
finance.yahoo.com logoEdited Transcript of IRMD earnings conference call or presentation 28-Apr-17 3:00pm GMT
finance.yahoo.com - April 29 at 9:08 AM
americanbankingnews.com logoIradimed Corp (IRMD) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - April 29 at 1:27 AM
americanbankingnews.com logoIradimed Corp (IRMD) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - April 29 at 1:22 AM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : April 28, 2017
finance.yahoo.com - April 28 at 6:57 PM
americanbankingnews.com logoIradimed Corp (IRMD) Issues FY17 Earnings Guidance
www.americanbankingnews.com - April 28 at 10:21 AM
americanbankingnews.com logoIradimed Corp (IRMD) Updates Q2 Earnings Guidance
www.americanbankingnews.com - April 28 at 10:20 AM
finance.yahoo.com logoIRADIMED CORPORATION Announces First Quarter 2017 Financial Result
finance.yahoo.com - April 28 at 9:55 AM
finance.yahoo.com logoIRadimed reports 1Q loss
finance.yahoo.com - April 28 at 9:55 AM
finance.yahoo.com logoInvestor Network: iRadimed Corp to Host Earnings Call
finance.yahoo.com - April 28 at 9:55 AM
americanbankingnews.com logoIradimed Corp (IRMD) Earning Favorable News Coverage, Analysis Shows
www.americanbankingnews.com - April 21 at 10:13 PM
finance.yahoo.com logoIRADIMED CORPORATION to Hold 2017 First Quarter Financial Results Conference Call on April 28th
finance.yahoo.com - April 20 at 11:23 AM
americanbankingnews.com logoIradimed Corp (IRMD) Given Coverage Optimism Rating of -0.12
www.americanbankingnews.com - April 18 at 6:51 PM
americanbankingnews.com logoIradimed Corp (IRMD) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 9 at 11:51 AM
finance.yahoo.com logoETFs with exposure to IRadimed Corp. : April 7, 2017
finance.yahoo.com - April 7 at 5:50 PM
americanbankingnews.com logo Iradimed Corp (IRMD) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 3 at 11:37 PM
streetinsider.com logoIradimed Corp. (IRMD) Names John McCreery as COO
www.streetinsider.com - March 30 at 11:20 PM
finance.yahoo.com logoIRADIMED Names John McCreery Chief Operating Officer
finance.yahoo.com - March 30 at 6:20 PM

Social

Chart

iRadimed Corporation (IRMD) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff